The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study

OBJECTIVES: Given the high occurrence of asymptomatic subsets, the true prevalence of SARS-CoV-2 infection in rheumatic patients is still underestimated. This study aims to evaluate the seroprevalence of SARS-CoV-2 antibodies in rheumatic musculoskeletal diseases (RMD) patients receiving immunomodul...

Descripción completa

Detalles Bibliográficos
Autores principales: Favalli, Ennio Giulio, Gobbini, Andrea, Bombaci, Mauro, Maioli, Gabriella, Biggioggero, Martina, Pesce, Elisa, Favalli, Andrea, Martinovic, Martina, Fabbris, Tanya, Marchisio, Edoardo, Bandera, Alessandra, Gori, Andrea, Abrignani, Sergio, Grifantini, Renata, Caporali, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963104/
https://www.ncbi.nlm.nih.gov/pubmed/35360719
http://dx.doi.org/10.3389/fmed.2022.850858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963104/
https://www.ncbi.nlm.nih.gov/pubmed/35360719
http://dx.doi.org/10.3389/fmed.2022.850858

Ejemplares similares